Decina Pharma Private Limited, a active private limited company, was established on 20 April 2017 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909PN2017PTC170011. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sherrin Pulikathotil James (Director), Jaji Puthen Parambil James (Director). Past directors included Pratik Hasmukhray Doshi, Karan M Trivedi, Het Sanjay Sanghavi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 108, Building No.G, S.No.73/1, Geras Emerald City South, Kharadi,, Pune, Maharashtra, 411014.
U51909PN2017PTC170011
170011
20 April 2017
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Decina Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sherrin Pulikathotil James | Director | 20 Apr 2017 | Current |
| Jaji Puthen Parambil James | Director | 20 Apr 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jun 2021 | Past |
| Pramod Abcsdd | Director | 02 Jun 2021 | Past |
| Pramod Abcsdd | Director | 02 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Decina Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 75.25% increase. The company also saw a substantial improvement in profitability, with a 118.6% increase in profit. The company's net worth Soared by an impressive increase of 10.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Decina Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Decina Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Decina Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Decina Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Decina Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Decina Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
The activity Sherrin Pulikathotil James was appointed as a Director was appointed as a Director on 20 Apr 2017 & has been associated with this company since 8 years 7 months . was completed.
Progress on Jaji Puthen Parambil James was appointed as a Director was appointed as a Director on 20 Apr 2017 & has been associated with this company since 8 years 7 months . was documented.
Progress on Decina Pharma Private Limited was registered on 20 Apr 2017 with Roc Pune & aged 8 years 7 months as per MCA records. was documented.
The CIN of Decina Pharma Private Limited is U51909PN2017PTC170011.
Decina Pharma Private Limited is headquartered at Flat No. 108, Building No.G, S.No.73/1, Geras Emerald City South, Kharadi,, Pune, Maharashtra, 411014.
Decina Pharma Private Limited was incorporated on 20 April 2017.
The current directors of Decina Pharma Private Limited are
The primary industry of Decina Pharma Private Limited is Trade.
Decina Pharma Private Limited is unlisted.
The authorized capital of Decina Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Decina Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX